Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004248
Recruitment Status : Completed
First Posted : March 31, 2004
Last Update Posted : March 7, 2011
Information provided by:
Roswell Park Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2000
  Study Completion Date : May 2001